Dose-escalation with CHARTWEL (Continuous Hyperfractionated Accelerated Radiotherapy Week-End Less) Combined with Neo-adjuvant Chemotherapy in the Treatment of Locally Advanced Non-small Cell Lung Cancer
- 1 October 2002
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 14 (5) , 352-360
- https://doi.org/10.1053/clon.2002.0121
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final report of an Australian multi-centre trialRadiotherapy and Oncology, 1999
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- Hyperfractionated radiotherapy for clinical stage II non-small cell lung cancerRadiotherapy and Oncology, 1999
- Concurrent radiochemotherapy for patients with stage III non-small–cell lung cancer (NSCLC): long-term results of a phase II studyInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small-cell carcinoma of the lungInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in rtog 88-08/ECOG 4588International Journal of Radiation Oncology*Biology*Physics, 1997
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 TrialJNCI Journal of the National Cancer Institute, 1996
- Concurrent chemotherapy (CT) and radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC): a reviewLung Cancer, 1994
- N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 GY by the radiation therapy oncology groupInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology groupCancer, 1987